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Abstract
Pathogenic biallelic variants in POL3RA have been associated with different disorders
characterized by progressive neurological deterioration. These include the 4H leuko-
dystrophy syndrome (hypomyelination, hypogonadotropic hypogonadism, and
hypodontia) and adolescent-onset progressive spastic ataxia, as well as Wiedemann–
Rautenstrauch syndrome (WRS), a recognizable neonatal progeroid syndrome. The
phenotypic differences between these disorders are thought to occur mainly due to
different functional effects of underlying POLR3A variants. Here we present the
detailed clinical course of a 37-year-old woman in whom we identified a homozygous
synonymous POLR3A variant c.3336G>A resulting in leaky splicing r.[3336ins192, =,
3243_3336del94]. She presented at birth with intrauterine growth retardation, lipo-
dystrophy, muscular hypotonia, and several WRS-like facial features, albeit without
sparse hair and prominent scalp veins. She had no signs of developmental delay or
intellectual disability. Over the years, above characteristic facial features, she showed
severe postnatal growth retardation, global lipodystrophy, joint contractures, thoracic
hypoplasia, scoliosis, anodontia, spastic quadriplegia, bilateral hearing loss, aphonia,
hypogonadotropic hypogonadism, and cerebellar peduncles hyperintensities in brain
imaging. These manifestations partially overlap the clinical features of the previously
reported POLR3A-associated disorders, mostly mimicking the WRS. Thus, our study
expands the POLR3A-mediated phenotypic spectrum and suggests existence of a
phenotypic continuum underlying biallelic POLR3A variants.
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1 | INTRODUCTION
RNA polymerase (Pol) III is one of three eukaryotic nuclear RNA poly-
merases, responsible for transcription of small noncoding genes such
as ribosomal 5S RNAs, transfer RNAs (tRNAs), signal recognition parti-
cle (SRP) RNAs, mitochondrial RNA-processing RNAs (RMRP), H1
RNAs (RPPH1), U6 and 7SK small nuclear RNA (snRNA) (Jarrous
et al., 2021; Yeganeh & Hernandez, 2020). Pol III is composed of
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17 protein subunits, and the largest subunit is encoded by POLR3A
(#MIM 614258) (Sepehri & Hernandez, 1997; Yeganeh &
Hernandez, 2020).
Pathogenic biallelic variants in POL3RA were first identified in
individuals affected by a hypomyelinating leukodystrophy and
variable degree of tremor-ataxia, oligo- and hypodontia, and hypogo-
nadotropic hypogonadism (Bernard et al., 2011). This neurodegenera-
tive condition, which is also known as the 4H leukodystrophy
syndrome (hypomyelination, hypogonadotropic hypogonadism, and
hypodontia) (Bernard et al., 2011), is characterized by high inter- and
intra-familial variability regarding the age of onset and progression of
neurologic symptoms (Wolf et al., 2014). Noteworthy, hypomorphic
biallelic POLR3A variants were also identified in individuals affected
by adolescent-onset progressive spastic ataxia with no overt
hypomyelinating leukodystrophy (Minnerop et al., 2017). Moreover,
Jay et al. identified compound heterozygosity for two null variants in
POLR3A in an individual that resembled Wiedemann–Rautenstrauch
syndrome (WRS) (Jay et al., 2016), a neonatal/congenital segmental
progeroid syndrome (Lessel & Kubisch, 2019; Paolacci et al., 2017).
WRS, first described in 1977 by Thomas Rautenstrauch and
Friedemann Snigula (Rautenstrauch & Snigula, 1977) followed by
Hans Rudolph Wiedemann in 1979 (Wiedemann, 1979), is character-
ized by recognizable facial features, intrauterine growth retardation
with subsequent severe failure to thrive, natal teeth followed by
hypodontia or anodontia of permanent teeth, thin and atrophic skin,
global developmental delay, progressive neurological deterioration,
generalized lipodystrophy with local fat pads, and associated cachectic
appearance (Lessel & Kubisch, 2019; Paolacci et al., 2017). We and
others independently confirmed that biallelic loss-of-function variants
in POLR3A cause WRS (Lessel et al., 2018; Paolacci et al., 2018;
Wambach et al., 2018). In addition, heterozygous missense variants in
POLR3A and POLR3C, as well as combination of variants in both
genes, have been associated with increased susceptibility to severe
varicella zoster virus (VZV) infection in otherwise unremarkable indi-
viduals (Ogunjimi et al., 2017).
Here, we report a detailed clinical course in a 37-year-old woman
harboring a POLR3A homozygous synonymous variant, which results
in aberrant RNA splicing and leads to a combination of clinical signs
and symptoms previously associated with POLR3A-pathologies
although mostly resembling WRS.
2 | MATERIALS AND METHODS
2.1 | Human subjects
All biological samples and images were obtained following written
informed consent from the affected individual and her family members.
Initial patient contact was made with The Progeria Research Foundation
(PRF) International Patient Registry (www. Progeriaresearch.org), this
study has ongoing institutional review board approval from the Hasbro
Children's Hospital. In addition, the study was performed in accordance
with protocols approved by the Ethics Committee of the Hamburg
Chamber of Physicians (PV 3802). The study was performed in accor-
dance with the Declaration of Helsinki protocols.
2.2 | Genetic analyses
DNA samples from whole blood were isolated by standard proce-
dures. Trio-whole exome sequencing with DNA samples of both
healthy parents and the index patient was performed at the Cologne
Center for Genomics on two lanes of an Illumina GAIIx Sequencer
using a single read 150 bp protocol after enrichment of exonic and
splice-site sequences with the Agilent SureSelect Human All Exon
50 Mb kit as previously described (Lessel et al., 2018). Variant annota-
tion and bioinformatic filtering of identified variants was performed as
described before (Lessel et al., 2018). Sanger sequencing was per-
formed to validate candidate variants and perform segregation ana-
lyses within the family. All primer pairs are available upon request.
2.3 | POLR3A transcript analysis
Total RNA was extracted using the PAXgene Blood RNA Kit IVD
(Qiagen, Hilden, Germany) and RT-PCR was performed as previously
described (Girisha et al., 2016). Briefly, RT-PCR was performed using
the OneStep RT-PCR Kit (Qiagen). Primer sequences were as follows:
Forward primer 50-GACCCTGAAGACTTTCCACTTTGC-30 and reverse
primer 50-TCTCAGCGTTCACTTCCAGTCTCA-30. Resulting products
were electrophoresed, gel-extracted using the QIAquick Gel Extrac-
tion Kit (Qiagen), and subjected to Sanger sequencing. Sequence
traces were assembled, aligned and analyzed with the Seqman soft-
ware (DNASTAR Lasergene, Madison, WI, USA). Image Lab™ Software
was used to calculate the relative abundance of POLR3A transcripts.
3 | RESULTS
3.1 | Clinical report
The proband (Figure 1), a female born at 40 weeks of gestation, was
the firstborn of healthy parents who are likely distantly related. She
has a younger unaffected sister. Her birthweight was 2600 g (2.07
SD), length 53 cm (+0.59 SD), and occipitofrontal head circumference
(OFC) 31 cm (3.00 SD). At birth, she had a triangular face, sparse
eyebrows, deep set and closely spaced eyes with low positioning of
the eyeballs (lower eyelid covering part of the cornea), bilateral micro-
phthalmia, coloboma on left eye, small mouth, two natal teeth in the
upper jaw, high-arched palate, malformed and low-set ears, small
mouth, pointed chin, and mandibular underdevelopment. She also had
global lipodystrophy, hip dysplasia, muscular hypotonia, and adducted
thumbs. Karyotyping gave unremarkable result. Milestones of motor
development and language development were unremarkable. Head
and neck control was achieved at 3 months, she sat without support
at 8 months and made first steps at 11 months of age. She spoke
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short sentences at 2 years of age. The proband reported that her
whole early postnatal development was characterized by poor weight
gain and severe growth retardation. At the age of 6 and 8 years, she
underwent surgical procedures to remove large subdural hematomas
that both occurred after a fall and head injury. The proband reports
on deterioration of motor abilities and general muscular weakness fol-
lowing subdural hematomas, she could not run as fast as previously
but could still walk independently for around 5 km. Routine laboratory
analyses performed after the second surgery, at the age of 8 years,
revealed a mild aminoaciduria, and elevated cholesterol and triglycer-
ide values. X-rays of the spine and pelvis revealed ankylosing spondy-
litis and thoracic hypoplasia. By the age of 8 years, she had complete
anodontia in the lower jaw. Intelligence quotient (IQ) was measured
116. Endocrinology workup at the age of 15 years showed elevated
levels of growth hormone and IGF-1, as well as low levels of proges-
terone, luteinizing hormone (LH), and follicle-stimulating hormone
(FSH). Analysis of testosterone, prolactin, and estradiol as well as thy-
roid function test gave normal results. X-ray of the wrist suggested a
bone age of 12 years. In addition, audiometry confirmed a progressive
conductive hearing loss. Moreover, she developed a seborrhoeic der-
matitis on the scalp. At the age of 20 years, she had an almost com-
plete absence of secondary sexual characteristics including the
absence of menarche. At the age of 26 years, she had a long lasting
febrile infection with recurrent diarrhea of unknown origin. The pro-
band reports further major deterioration of motor capacities after this
infection of unknown origin. She was not able to climb stairs or walk
larger distances anymore. Her weight had dropped from 31 to 22 kg,
and she experienced gradual voice changes and could barely speak.
Afterwards she took special measures, primarily avoiding unnecessary
personal contacts, during the flu season and especially since onset of
the SARS-Cov-2 pandemics. She reports no severe infections after
her 26th birthday. At the age of 27 years, she was diagnosed with
F IGURE 1 Clinical characteristics of the proband. Proband at the age of 12 months (a), 3 years (b), 8 years (c), 12 years (d), and 34 years
(e and f). Please note the triangular face, sparse eyebrows, deep set and closely spaced eyes with low positioning of the eyeballs, bilateral
microphthalmia, small mouth, malformed and low-set ears, small and pointed chin. Progressive global lipodystrophy, thin arms and legs, and
severely cachexic appearance at the age of 34 years (f)
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Type 2 hyperlipoproteinemia. Her motor problems progressed to a
spastic quadriplegia and she was unable to walk unaided. Brain MRI at
the age of 33 years revealed cortical lesions of the angular and fusi-
form gyri, likely consequences of traumatic brain injuries, increased T2
signal intensity in the dorsal spinal cord, as well as corticospinal tract
(CST) and cerebellar peduncles hyperintensities on MRI-fluid attenu-
ated inversion recovery (FLAIR). Currently at the age of 37 years, her
weight is 24 kg and height 148 cm. She exhibits a prematurely aged
facial appearance, with a triangular face, small and deep set eyes, a
beaked nose, complete anodontia, malformed and low-set ears, and
mandibular underdevelopment. She has thin and sparse hair on the
head, global lipodystrophy, thin arms and legs, spastic quadriplegia,
scoliosis, a bilateral conductive hearing loss and is aphonic (Figure 1).
Noteworthy, despite the abovementioned severe health issues, she
gained university education.
3.2 | Genetic analyses
In order to identify the putative genetic cause, we performed trio
whole-exome sequencing (trio-WES) with a DNA sample of the pro-
band and her both parents. Approximately 96% of target sequences
were covered at least 10-fold with a mean coverage of 88x. Bioinfor-
matic filtering identified no de novo variants and no putatively com-
pound heterozygous variants with a minor allele frequency (MAF)
< 0.001 according to gnomAD. We next searched for rare, homozy-
gous variants. This analyses revealed seven homozygous variants in
six genes, all of which were within regions of homozygosity in line
with distant consanguinity of the parents. (Tables S1 and S2). Notably,
we identified a synonymous variant c.3336G>A, p.(Glu1112Glu),
affecting the last nucleotide in Exon 25 of POLR3A (NM_007055.4).
Sanger sequencing-based, subsequent segregation analyses with DNA
samples of the proband, her both parents and unaffected sister,
excluded four of these variants (Table S2). Due to similarities to previ-
ously reported POLR3A-cases (Jay et al., 2016; Lessel et al., 2018;
Paolacci et al., 2018; Wambach et al., 2018) and as the Splice Site Pre-
diction by Neural Network (Berkeley Drosophila Genome Project;
http://www.fruitfly.org/seq_tools/splice.html) predicted a weaker
splice donor site with a score of 0.83 compared to a score of 1.00 that
is assigned to the wild-type sequence, we further analyzed the impact
of this synonymous POLR3A variant.
To test for the predicted splicing defect of the variant
c.3336G>A, we performed RT-PCR analysis with RNA isolated from
lymphocytes of the proband and one control individual. This analysis
revealed in the control individual only one amplicon of the expected
wild-type size (300 bp). Analysis of the proband RNA yielded three
amplicons, one amplicon of the expected wild-type size (300 bp)
with a relative abundance of 30%, one stronger and larger amplicon
of 500 bp with a relative abundance of 65%, and one very weak
amplicon of 200 bp with a relative abundance of 5%. Sanger
sequencing revealed that the larger amplicon (500 bp) resulted from
insertion of intron 25 whereas the lower amplicon (200 bp) resulted
from skipping of exon 25 (Figure 2). Thus we conclude that the identi-
fied synonymous variant results in leaky splicing at least in blood. It
preferentially results in intron 25 insertion, r.[3336ins192] on the
RNA level, which is predicted to lead to a premature termination
codon p.(Glu1112Glufs*7) on the protein level. The less abundant
alternatively spliced transcript resulting from skipping of Exon 25 leads
to r.[3243_3336del94] on the RNA level, and also likely leads to a pre-
mature termination codon p.(Ser1081Argfs*28). Noteworthy, in addi-
tion to these alternatively spliced transcripts we also identified the
wild-type transcript of intermediate abundancy.
F IGURE 2 POLR3A transcript analysis. (a) POLR3A transcript analysis was performed using lymphocyte-derived RNA of the proband (P) and
an unaffected individual (C+). The 299-bp wild-type RT-PCR amplicon was amplified in both the proband and the control (C+), while no product
was yielded in the negative control (C, no template). Two further PCR products were identified. One stronger and larger amplicon of 500 bp,
suggestive for Intron 25 inclusion (299 + 192 = 491), and one very weak amplicon of 200 bp, suggestive for exon 25 skipping (299–94 = 205).
Molecular marker (M) indicates the reference bands. (b) Sanger sequencing of the two alternative amplicons confirmed the intron 25 inclusion in
the larger amplicon, and the skipping of exon 25 in the lower amplicon
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Weight at birth <P3 + 17/19 4/5 ? ?
Length at birth <P3  5/13 4/5 ? ?
OFC at birth <P3 + 4/14 2/4 ? ?
Craniofacial features
Triangular face + 16/19 5/5 ? ?
Sparse scalp hair  16/19 5/5 ? ?
Thin/translucent skin  18/18 5/5 ? ?
Prominent scalp veins  17/17 5/5 ? ?
Closely spaced eyes + 3/9 5/5 ? ?
Deeply set eyes + 12/12 3/4 ? ?
Microphthalmia +   ? ?
Coloboma +   ? ?
Lower eyelid covering part
of the cornea
+ 19/19 5/5 ? ?
Ear abnormalities + 17/18 4/5 ? ?
Small mouth + 15/18 4/5 ? ?
Natal teeth + 17/19 3/5 18/94 ?
Pointed chin + 13/18 5/5 ? ?
Mandibular
underdevelopment




Motor development delay  4/8 ? 54/103 1/29
Intellectual disability  8/13 ? 54/103 5/29
Ataxia + 2/11 1/3 +* 29/29
Tremor  3/11 ? +* 15/29
Loss of independent walking + ? ? 28/54 20/20
Hearing loss + 2/13 ?  0/29
Dysarthria + ? ? +* 16/29
Neurologic deterioration
after infection
+ ? ? 42/97 ?
Brain anomalies US/MRI
Structural brain anomalies  2/7 1/1 +** 1/21
Hypomyelination  0/4 ? 93/97 0/20
SCP hyperintensity (FLAIR) + ? ?  11/14
Metabolic anomalies
Lipodystrophy + 19/19 6/6  ?
Hyperlipoproteinemia + ? ? ? ?
Hypertriglyceridaemia + 2/4 ? ? ?
Hypogonadism + ? ? 47/62 ?
Amenorrhea + ? ? + ?
Growth hormone Elevated ? ? Deficiency 5/10 ?
(Continues)
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4 | DISCUSSION
Wiedemann–Rautenstrauch syndrome (WRS), caused by biallelic loss-
of-function variants in POLR3A (Jay et al., 2016; Lessel et al., 2018;
Paolacci et al., 2018; Wambach et al., 2018), is a neonatal/congenital
segmental progeroid syndrome accompanied by a decreased life
expectancy. Literature makes note of only a few individuals who were
still alive at the age of 20 years (Paolacci et al., 2017; Wambach
et al., 2018). We present here a detailed clinical course of a 37-year-
old woman whose clinical characteristics and facial features mostly
resembled those of individuals affected by the POLR3A-associated
WRS (Table 1). In line with the clinical assumption trio-WES analysis
identified a homozygous synonymous variant in POLR3A that affects
the last nucleotide in Exon 25 and leads to leaky splicing defects. In
more detail, her clinical presentation during the perinatal and early
childhood period are highly similar to what is documented in WRS
(Lessel et al., 2018; Paolacci et al., 2017; Wambach et al., 2018).
Albeit, she did not have sparse scalp hair, nor thin and translucent skin
with prominent scalp veins, findings that were observed in almost all
previously described WRS-cases bearing POLR3A biallelic pathogenic
variants. Moreover, as compared to other WRS cases she had no
global developmental delay, nor intellectual disability. Actually, despite
severe health issues she gained a university degree. Postnatal growth
retardation with poor weight gain, global lipodystrophy, joint contrac-
tures, anodontia and progressive deterioration of neurological func-
tions, including muscle weakness that progressed to spastic
quadriplegia, progressive bilateral hearing impairment, and aphonia,
are mostly in line with previously documented WRS cases that sur-
vived beyond the early childhood (Lessel et al., 2018; Paolacci
et al., 2017; Paolacci et al., 2018; Wambach et al., 2018).
Of note the presence of natal teeth and subsequent dental anom-
alies, progressive motor regression and spasticity, dysarthria, short
stature, and hypogonadotropic hypogonadism with primary
amenorrhea observed in the here presented individual are also com-
mon clinical findings in 4H leukodystrophy syndrome, another
POLR3A-associated disorder (Paolacci et al., 2017; Wolf et al., 2014).
4H leukodystrophy syndrome is further characterized by
hypomyelinating leukodystrophy, initial tremor and developmental
delay, in 50% of affected individuals, none of which have been
observed in the here presented individual (Wolf et al., 2014). Further-
more, whereas individuals with 4H leukodystrophy syndrome com-
monly have a growth hormone deficiency (Wolf et al., 2014), the here
presented individual actually had elevated levels of both growth hor-
mone and IGF-1. Interestingly, the here observed hyperintensities
along the cerebellar peduncles on MRI-fluid attenuated inversion
recovery (FLAIR) without hypomyelination have been observed in
individuals affected by adolescent-onset progressive spastic ataxia
harboring hypomorphic biallelic POLR3A variants (Minnerop
et al., 2017).
Our RT-PCR analysis showed that c.3336G>A can lead to leaky
splicing r.[3336ins192, =, 3243_3336del94]. Thus, above retaining
some wild-type transcript two alternatively spliced variants are gener-
ated, resulting either in inclusion of Intron 25 or skipping of Exon
25 both of which are predicted to lead to a truncated protein. Previ-
ous studies identified several intronic variants, some of which are
recurrent, that affect transcript processing in individuals affected by
WRS (Jay et al., 2016; Lessel et al., 2018; Paolacci et al., 2018;
Wambach et al., 2018). Moreover, c.1909+22G>A, shown to be a
hypomorphic allele, was observed in >80% of individuals affected by
the adolescent-onset progressive spastic ataxia (Minnerop
et al., 2017). Similarly, intronic variants, mostly in combination with a
missense variant on the other allele, were also identified in individuals
affected by 4H leukodystrophy (Wolf et al., 2014). It was initially
hypothesized that biallelic POLR3A null variants result in WRS,
whereas biallelic hypomorphic variants cause a milder 4H leukodys-













Abnormal dentition + 10/10 ? 71/98 11/20
Delayed bone age + ? ? ? ?
Short stature + 12/14 ? 47/91 ?
Kyphosis/scoliosis + 1/2 ? ? ?
Other anomalies
Cardiac anomalies  1/3 1/1 ? ?
Joint contractures + 3/3 ? ? ?
Abbreviations: +, present; , absent; ?, unknown; +*, reported as common without exact numbers; +**, thin corpus callosum is present in all cases after
the age of 17 years; WRS, Wiedemann–Rautenstrauch syndrome.
aJay et al. (2016).
bLessel et al. (2018).
cPaolacci et al. (2018).
dWambach et al. (2018).
eWolf et al. (2014).
fMinnerop et al. (2017).
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here presented individual harbors a variant, which results in leaky
splicing, resembling a somewhat milder form of WRS, and displays
some of the clinical features of both 4H leukodystrophy and late-
onset progressive spastic ataxia providing further evidence for a phe-
notypic continuum between POLR3A-pathologies. Clearly, further
functional studies aiming to decipher the impact of different POLR3A
variants, especially those within introns, are needed to provide a
molecular explanation for the observed differences in clinical presen-
tation and outcomes.
Lastly, respiratory problems, mostly due to infections (pneumonia),
are considered a major cause of death in WRS cases (Lessel &
Kubisch, 2019; Paolacci et al., 2017). Although, the individual presented
here had no history of severe respiratory infections, it is worth noting
that her condition severely deteriorated, both in terms of motor abilities
and weight loss, following an infection of unknown origin. Similarly
almost half of the individuals affected by 4H leukodystrophy experi-
enced neurologic deterioration following infections (Wolf et al., 2014).
Interestingly, missense variants in POLR3A have been linked to enhanced
susceptibility to severe outcome to VZV infection in otherwise
unremarkable individuals, whereby leukocytes display poor IFN produc-
tion and high replication of VZV upon infection, findings that can be
restored upon expression of wild-type POLR3A (Ogunjimi et al., 2017).
Taken together, these findings might warrant extra precautions for WRS
cases in avoiding infections at least in the first years of life. Such preven-
tive strategies could include strong hygiene measures and avoidance of
unnecessary physical contacts.
In conclusion, we present here a detailed clinical course of a
37-year-old woman who harbors a homozygous synonymous POLR3A
variant resulting in leaky splicing. She presented several facial features
characteristic for WRS but later on developed a somewhat milder clin-
ical outcome. In addition, she presented several phenotypic overlaps
with other POLR3A-related disorders, that is, 4H leukodystrophy and
adult-onset spastic ataxia. These findings provide further evidence for
a phenotypic continuum between POLR3A-related disorders and may
open the way to further studies aiming to provide a molecular under-
standing underlying pleiotropic effects of different POLR3A variants.
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